Dr Reddy's Laboratories has recalled over 3.3 lakh bottles of a drug used to treat high calcium levels in the blood and hyperparathyroidism from the US market due to manufacturing issues. According to the latest enforcement report from the US Food and Drug Administration (US FDA), Dr Reddy's is recalling 3,31,590 bottles of Cinacalcet tablets of multiple strengths from the US market due to CGMP (current good manufacturing practice) deviations.

The company said that this recall has been done due to the presence of N-nitroso Cinacalcet impurity in excess of the interim limit recommended by the FDA. New Jersey-based Dr. Reddy's Laboratories Inc., a unit of the Hyderabad-based drug company, is recalling 2,85,126 bottles of Cinacalcet tablets of 30 mg strength.

The affected lots were produced in India . Apart from this, the USFDA said that the drug manufacturer is recalling 35,880 and 10,584 bottles of 60 mg and 90 mg strengths. It has been said that the affected lots have been produced in India. US-based Dr. Reddy's Laboratories Inc. started the Class In Nationwide (US) recall on October 9 this year. The company's stock closed at Rs 1,262, down 0.97 per cent from its previous close. In the last one year, the company's stock has seen a rise of 19.89 per cent. The 52 week high of the stock is Rs 1,421.49.